If you have been looking into weight loss injections in Malaysia, two names keep coming up: Mounjaro and Ozempic. Both are weekly injections. Both have changed how doctors approach medical weight loss. And both are available at Nexus Clinic in Kuala Lumpur.
But they are not the same drug. They work differently, produce different results, and are better suited to different patients.
This guide breaks it all down in plain language, so you can walk into a consultation knowing exactly what to ask.
What Is Mounjaro (Tirzepatide)?
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication made by Eli Lilly. It was originally developed to treat type 2 diabetes, but its dramatic effect on body weight made it one of the most talked-about medications in weight management globally.
In Malaysia, Mounjaro received NPRA registration on 30 August 2025 under the registration number MAL24026013AZ. It is a prescription-only medication and must be obtained through a licensed medical clinic.
What makes Mounjaro different is its dual mechanism. It activates two hormone receptors at the same time: GLP-1 and GIP. Most weight loss injections only target one. This is why tirzepatide tends to produce stronger appetite suppression and greater fat loss than older medications.
What Is Ozempic (Semaglutide)?
Ozempic is the brand name for semaglutide, a once-weekly injection also developed primarily for type 2 diabetes. It was the first medication of its kind to gain widespread recognition for weight loss, and it remains one of the most prescribed weight loss injections in Malaysia today.
Ozempic works by activating the GLP-1 receptor only. This slows digestion, reduces hunger signals sent to the brain, and helps stabilise blood sugar levels. For most patients, this single-receptor approach still produces meaningful weight loss, typically between 10 and 15 percent of body weight over 68 weeks.
Ozempic is also available at Nexus Clinic, and our doctors have been prescribing it to patients across Kuala Lumpur and Petaling Jaya since it became widely available in Malaysia. You can read more on our Ozempic Malaysia treatment page.
How Mounjaro and Ozempic Work Differently
This is the part most patients get wrong. They assume both drugs are basically the same because they are both weekly injections for weight loss. They are not.
Ozempic acts on one pathway: GLP-1. This hormone tells your brain you are full and slows the movement of food through your stomach.
Mounjaro acts on two pathways: GLP-1 and GIP. The addition of GIP improves how your body responds to insulin and adds a second layer of appetite suppression. Think of it as two signals working together rather than one.
The clinical trial data reflects this difference clearly. In the SURMOUNT-1 trial, patients on Mounjaro lost an average of 15 to 22.5 percent of their body weight over 72 weeks. In the SUSTAIN trials for Ozempic, average weight loss was closer to 10 to 15 percent over a similar period.
That gap matters when you are deciding which drug to start with, especially if you have a significant amount of weight to lose.
Mounjaro vs Ozempic: Side-by-Side Comparison
| Feature | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) |
|---|---|---|
| Drug class | Dual GIP + GLP-1 agonist | GLP-1 agonist only |
| Injection frequency | Once weekly | Once weekly |
| Average weight loss | 15 to 22.5% | 10 to 15% |
| Starting dose in Malaysia | 2.5 mg weekly | 0.25 mg weekly |
| NPRA status in Malaysia | Approved Aug 2025 | Approved, widely available |
| Malaysia price (monthly est.) | RM 1,400 to RM 3,200 | RM 800 to RM 1,800 |
| Primary approved use | Type 2 diabetes + weight loss | Type 2 diabetes |
| Best suited for | Higher weight loss goals, Ozempic non-responders | First-line GLP-1 treatment |
Side Effects: What to Expect from Each
Both medications share a similar side effect profile because they both activate the GLP-1 pathway. The most common ones are:
- Nausea, particularly in the first few weeks
- Loose stools or constipation
- Reduced appetite (this is partly the intended effect)
- Mild fatigue when starting or increasing the dose
- Injection site reactions such as mild redness or itching
For most patients, these side effects are mild and improve after the body adjusts to the medication, usually within the first four to eight weeks.
Because Mounjaro is stronger, some patients notice more pronounced nausea when they first start or increase their dose. This is why both medications use a gradual titration schedule. Doctors at Nexus start patients at the lowest effective dose and only increase when the body is ready.
One side effect patients often ask about is facial volume loss, sometimes called Ozempic face or Mounjaro face. This happens when significant weight loss reduces fat in the face, causing a hollowed or gaunt appearance. It is not caused by the medication itself, but by the speed and scale of weight loss. If this is a concern, our team can discuss dermal fillers or Sculptra treatments that help restore facial volume during or after your weight loss programme.
How Much Do They Cost in Malaysia?
Price is one of the biggest practical differences between the two.
Ozempic is more established in the Malaysian market, which means supply is more stable and pricing tends to be lower. Most patients pay between RM 800 and RM 1,800 per month depending on the dose.
Mounjaro is newer and more potent. Monthly costs typically range from RM 1,400 to RM 3,200, again depending on dose. Patients who start on 2.5 mg and stay on a lower dose throughout will pay at the lower end. Those who escalate to 10 or 15 mg will pay more.
Neither medication is typically covered by insurance in Malaysia when used purely for weight loss. If you are being treated for type 2 diabetes, some insurers may contribute to the cost. Your doctor can advise you on this during consultation.
For full pricing details, visit our Mounjaro Malaysia page and our GLP-1 weight loss programme which includes both options.
Who Should Choose Mounjaro, and Who Should Choose Ozempic?
There is no universal answer here. The right choice depends on your starting weight, your medical history, your budget, and how your body responds to treatment.
Mounjaro may be a better fit if:
- You have 20 kg or more to lose
- You have tried Ozempic and found the results insufficient
- You have insulin resistance or type 2 diabetes alongside obesity
- You want the strongest clinically proven option available in Malaysia
- You have PCOS with weight gain as a primary concern
Ozempic may be a better fit if:
- You are starting a GLP-1 programme for the first time
- You want a more established, widely studied medication
- Your weight loss goal is modest (10 to 15 kg range)
- Budget is a significant consideration for you
- Your doctor recommends starting with a lower-intensity option
At Nexus Clinic, our doctors assess each patient individually before recommending either medication. A standard blood panel, BMI assessment, and review of any existing conditions are part of every initial consultation. Patients who have not responded well to Ozempic are commonly considered for Mounjaro as the next step.
Can You Switch from Ozempic to Mounjaro?
Yes, and it is more common than you might think. Some patients start on Ozempic, see good initial progress, and then plateau after several months. Switching to Mounjaro can restart that progress because the dual-receptor mechanism works differently from semaglutide.
A switch is not something you do abruptly. Your doctor will typically wait for Ozempic to clear your system before starting Mounjaro, and you will begin at the 2.5 mg starting dose regardless of how long you have been on semaglutide. The titration schedule then applies as normal.
If you are considering switching, book a consultation so your doctor can review your progress and decide whether a change is appropriate for you.
How Nexus Clinic Supervises Mounjaro and Ozempic Programmes
Both medications are prescription-only and carry real medical considerations. Nexus Clinic’s approach is to supervise every patient on a structured programme, not simply hand over a prescription and leave patients to manage on their own.
What this looks like in practice:
- An initial blood panel including fasting glucose, HbA1c, lipid profile, liver and kidney function
- A full medical history review to check for any contraindications
- A starting dose that matches your body’s readiness, not a fixed protocol
- Regular follow-up appointments to track weight loss, adjust dose, and manage any side effects
- Guidance on protein intake and diet to protect muscle mass during weight loss
- An exit plan so you know what happens when the programme ends
To find out which option is right for you, book a weight loss consultation at Nexus Clinic KL. Our doctors will review your case and recommend the most appropriate programme.
Frequently Asked Questions
Which is stronger, Mounjaro or Ozempic?
Mounjaro is clinically stronger in terms of average weight loss. Clinical trial data shows Mounjaro produces 15 to 22.5 percent average body weight reduction, compared to 10 to 15 percent for Ozempic. This is because Mounjaro activates two hormone receptors (GLP-1 and GIP) while Ozempic activates one (GLP-1).
Is Mounjaro available in Malaysia?
Yes. Mounjaro received NPRA approval in Malaysia on 30 August 2025, registered under MAL24026013AZ. It is a Group B prescription-only medicine and must be prescribed by a licensed doctor. Nexus Clinic in Kuala Lumpur offers Mounjaro as part of a doctor-supervised weight loss programme.
Can I take Mounjaro and Ozempic together?
No. These medications should never be taken together. Both act on the GLP-1 pathway, and combining them significantly raises the risk of serious side effects including severe nausea, hypoglycemia, and pancreatitis. If you want to switch from one to the other, your doctor will guide you through the process safely.
How long does it take to see results with Mounjaro?
Most patients notice appetite changes within the first two to four weeks. Visible weight loss typically becomes apparent at the four to eight week mark. Significant results, in the 10 percent body weight reduction range, are usually seen at the three to six month point with consistent use and dose titration.
What happens if I stop taking Mounjaro or Ozempic?
Weight regain is common after stopping either medication, particularly if lifestyle changes have not been embedded alongside the programme. This is why Nexus Clinic builds an exit plan into every patient’s programme from the start. The goal is to use the medication to establish new eating habits and baseline weight, then transition to maintenance. Your doctor will advise you on timing and what support is available after the programme ends.
How much does Mounjaro cost per month in Malaysia?
Monthly costs for Mounjaro in Malaysia typically range from RM 1,400 to RM 3,200 depending on the dose. Patients on the starting 2.5 mg dose pay at the lower end. Those on higher doses (10 mg or 15 mg) pay more. Visit our Mounjaro Malaysia page for current pricing at Nexus Clinic.